P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines

Por Shirsath, Nitesh P, Manohar, Sonal M, Joshi, Kalpana S
Publicado em 2012

Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers

Por Rathos, Maggie J, Joshi, Kavita, Khanwalkar, Harshal, Manohar, Sonal M, Joshi, Kalpana S
Publicado em 2012

Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells

Por Rathos, Maggie J, Khanwalkar, Harshal, Joshi, Kavita, Manohar, Sonal M, Joshi, Kalpana S
Publicado em 2013

A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells

Por Manohar, Sonal M, Padgaonkar, Amol A, Jalota-Badhwar, Archana, Sonawane, Vinay, Rathos, Maggie J, Kumar, Sanjay, Joshi, Kalpana S
Publicado em 2011